CN Patent
CN102552114A — 甲硝唑眼用凝胶及其制备方法和用途
Assigned to Individual · Expires 2012-07-11 · 14y expired
What this patent protects
甲硝唑眼用凝胶及其制备方法和用途,所属医药技术领域,涉及药物有效成分甲硝唑,首次制成眼用凝胶,应用于防治蠕虫螨感染的睑缘炎、睑腺炎、结膜炎以及睑板腺功能障碍所致的干眼症,应用于防治配戴角膜接触镜过程中棘阿米巴原虫以及厌氧菌感染。甲硝唑眼用凝胶,由甲硝唑和药物可接受的载体组成,以重量计每100g甲硝唑眼用凝胶中甲硝唑用量为0.1~3.0g。
USPTO Abstract
甲硝唑眼用凝胶及其制备方法和用途,所属医药技术领域,涉及药物有效成分甲硝唑,首次制成眼用凝胶,应用于防治蠕虫螨感染的睑缘炎、睑腺炎、结膜炎以及睑板腺功能障碍所致的干眼症,应用于防治配戴角膜接触镜过程中棘阿米巴原虫以及厌氧菌感染。甲硝唑眼用凝胶,由甲硝唑和药物可接受的载体组成,以重量计每100g甲硝唑眼用凝胶中甲硝唑用量为0.1~3.0g。
Drugs covered by this patent
- Xdemvy (LOTILANER) · Tarsus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.